3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Triple Negative Breast Neoplasms
13
Breast Neoplasms
11
Carcinoma, Transitional Cell
6
Carcinoma, Non-Small-Cell Lung
5
Urinary Bladder Neoplasms
4
Neoplasm Metastasis
4
Lung Neoplasms
3
Small Cell Lung Carcinoma
2
Urothelial Bladder Carcinoma
1
Salivary Gland Neoplasms
1
Recurrent Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma
1
Prostatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasm, Residual
1
Muscle Invasive Bladder Urothelial Carcinoma
1
Metastatic Urothelial Cancer
1
Lung Diseases
1
Locally Advanced or Metastatic Unresectable Urothelial Cancer
1
Localized Muscle Invasive Bladder Urothelial Carcinoma
1
Liver Failure
1
HRD Cancer
1
Glioblastoma
1
Extensive Stage Small Cell Lung Cancer (ES-SCLC)
1
Drug-Related Side Effects and Adverse Reactions
1
Carcinoma, Small Cell
1
Brain Neoplasms
1
Advanced Solid Tumors
1
Interventions
Oxaliplatin
29
Fluorouracil
23
Capecitabine
19
pembrolizumab
17
Nivolumab
17
Leucovorin
16
Docetaxel
10
Paclitaxel
9
Drug Therapy
9
Cisplatin
9
fludarabine
8
Trastuzumab
8
S 1 (combination)
8
Cyclophosphamide
8
Specimen Handling
7
trastuzumab deruxtecan
6
Bevacizumab
6
Magnetic Resonance Spectroscopy
5
Biopsy
5
zolbetuximab
4
Irinotecan
4
Carboplatin
4
zimberelimab
3
sintilimab
3
olaparib
3
fludarabine phosphate
3
durvalumab
3
atezolizumab
3
aldesleukin
3
XELOX
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Stomach Neoplasms
×
sacituzumab govitecan
×
90 days
×
Clear all
No trials found.